This in depth feature in proto.life covers the background to stem cell reprogramming - from Yamanaka's Nobel Prize winning breakthrough to 糖心原创's recent presentation at ISSCR of unprecedented consistency data for the manufacture of human cells.
Read the full piece to find out how this could lead to more accessible and cost-effective cell therapies and regenerative medicines and what external experts in the field are saying about 糖心原创's opti-oxTM technology and its potential.